Mark Hannibal
- Virology top 5%
- HIV Research and Treatment 6
- Genetics top 5%
- Connective tissue disorders research 6
- Genomics and Rare Diseases 4
- Genetic Syndromes and Imprinting 3
- Molecular Biology top 10%
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
- Developmental Biology top 10%
- Immunology top 10%
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 5
- Co-authors
- Jeffrey W. InnisCatherine E. KeeganRobert E. ShapiroBernd WollnikEthylin Wang JabsMary Beth DinulosOtto DaniëlsSimeon A. Boyadjiev
- Cited by
- VirologyGeneticsMolecular Biology
- Partner nations
- United StatesBelgiumNew Zealand
In The Last Decade
Mark Hannibal
46 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 93
- Virology 159
- Genetics 556
- Molecular Biology 960
- Developmental Biology 27
- Immunology 236
Countries citing papers authored by Mark Hannibal
This map shows the geographic impact of Mark Hannibal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hannibal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hannibal more than expected).
Fields of papers citing papers by Mark Hannibal
This network shows the impact of papers produced by Mark Hannibal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hannibal. The network helps show where Mark Hannibal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Hannibal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 15 | |
| 3 | 2020 | 1 | |
| 4 | 2019 | 25 | |
| 5 | 2016 | 25 | |
| 6 | 2015 | 49 | |
| 7 | 2010 | 11 | |
| 8 | 2010 | 42 | |
| 9 | 2010 | 97 | |
| 10 | 2009 | 47 | |
| 11 | 2009 | 22 | |
| 12 | 2009 | 35 | |
| 13 | 2008 | 28 | |
| 14 | 2007 | 21 | |
| 15 | 2006 | 16 | |
| 16 | 2006 | 26 | |
| 17 | 2003 | 487 | |
| 18 | 1999 | 24 | |
| 19 | 1999 | 123 | |
| 20 | 1999 | 11 |
About Mark Hannibal
Mark Hannibal is a scholar working on Virology, Genetics, Immunology, Developmental Biology and Genetics, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Connective tissue disorders research (6 papers), HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (6 papers), RNA modifications and cancer (5 papers), T-cell and B-cell Immunology (5 papers), Genomics and Rare Diseases (4 papers), Epigenetics and DNA Methylation (4 papers) and Genetic Syndromes and Imprinting (3 papers). The work is most often cited by research in Virology (159 citations), Genetics (556 citations), Molecular Biology (960 citations), Developmental Biology (27 citations) and Immunology (236 citations). Mark Hannibal has collaborated with scholars based in United States, Belgium and New Zealand. Frequent co-authors include Jeffrey W. Innis, Catherine E. Keegan, Robert E. Shapiro, Bernd Wollnik, Ethylin Wang Jabs, Mary Beth Dinulos, Otto Daniëls, Simeon A. Boyadjiev, William A. Paznekas and David M. Markovitz. Their work appears in journals such as Journal of Virology, Blood, Human Molecular Genetics, Immunogenetics and Pediatric Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.